Early versus late start of immunosuppressive therapy in idiopathic membranous nephropathy: a randomized controlled trial

Abstract

In high-risk patients with iMN, immunosuppressive treatment is effective in inducing a remission. Early treatment shortens the duration of the nephrotic phase, but does not result in better preservation of renal function. Our study indicates that treatment decisions must be based on risk and benefit assessment in the individual patient.